Skip to main content
Fig. 3 | Arthritis Research & Therapy

Fig. 3

From: Impact of serum interleukin-22 as a biomarker for the differential use of molecular targeted drugs in psoriatic arthritis: a retrospective study

Fig. 3

Comparison of cytokine concentration among the IL-22-high group, IL-22-low group, and healthy controls. Data are presented as median (IQR). Serum cytokine concentrations were compared among patients with high IL-22 concentrations (n=25), patients with low IL-22 concentrations (n=22), and healthy controls (HC) (n=5). *p <0.05, by Kruskal-Wallis test with Dunn’s correction

Back to article page